Valiant Navion™ VNMC3731C207TU (UDI 00763000261030)Recalls & reported problems
Medtronic, Inc. · STENT GRAFT VNMC3731C207TU VAL NAV CS TP · Class 3 · Implant
All models of Valiant Navion (137)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00763000261030), received between May 24, 2021 and Sep 13, 2023 — classified as 2 injuries.
The most frequently reported specific device problem is “Leak/Splash” (2 reports).
1 FDA recall record name this device's identifier, 1 still open.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Recalls naming this device
- Feb 12, 2021Class IOpen, Classified
Due to the presence of type IIIb endoleaks, stent fractures, and stent ring enlargement.
Z-1201-2021 · Root cause: Under Investigation by firm · Recall details · FDA record ↗
Most reported problems
Device problems
- Leak/Splash2
- Fracture1
Patient problems
- Insufficient Information1
- Pain1
- Pleural Effusion1
- Syncope/Fainting1
- Valvular Insufficiency/ Regurgitation1
- Vascular Dissection1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjurySep 13, 2023Fracture; Leak/Splash; Fracture; Leak/Splash
A VALIANT NAVION STENT GRAFT ((B)(6)) WAS IMPLANTED IN A ENDOVASCULAR TREATMENT OF A TYPE A AORTIC DISSECTION ON THE (B)(6) 2020. A HEMI ARCH REPAIR WAS ALSO PERFORMED. FOUR MORE VALIANT NAVION STENT GRAFTS (B)(6) WERE IMPLANTED 2 MONTHS LATER FOR THE TREATMENT OF A TYPE A AORTIC DISSECTION WITH DISTAL EXTENSION AND A SYMPTOMATIC DISTAL THORACIC AORTIC ANEURYSM. DURING THE SECOND PROCEDURE, AN AORTOGRAPHY AND INTRAOPERATIVE VASCULAR ULTRASOUND REVEALED A WELL POSITIONED PREVIOUS TVAR IN THE TRUE LUMEN COVERING THE ORIFICE OF THE LEFT SUBCLAVIAN ARTERY, WHICH WAS COILED PREVIOUSLY. A TYPE I ENDOLEAK WITH FALSE LUMEN MEASURING 31 X 34MM WAS ALSO NOTED. USING A NON MDT SHEATH, THE 37 X 31 X 207MM VALIANT NAVION WAS DEPLOYED FIRSTLY IN THE TRUE LUMEN FOLLOWED BY THE 31 X 25 X 173MM STENT GRAFT WHICH WAS EXTENDED DOWN TO THE CELIAC ARTERY. SUBSEQUENTLY, INTRAVASCULAR ULTRASOUND SHOWED EXCELLENT PLACEMENT OF THE STENT GRAFTS WITH WIDELY OPENED CELIAC ARTERY. COMPLETION ANGIOGRAM REVEALED GOOD FLOW IN THE TRUE LUMEN. THERE WAS STILL FLOW AND PROXIMAL LEAK OBSERVED AT THE LEVEL OF THE PROXIMAL DESCENDING THORACIC AORTA. THEREFORE, THE FALSE LUMEN WAS STENTED WITH A 34 X 28 X 207MM STENT GR
Patient problems: Insufficient Information
MAUDE report 17736055 ↗InjuryMay 24, 2021Leak/Splash; Leak/Splash
A VALIANT NAVION STENT GRAFT WAS IMPLANTED IN THE PATIENT FOR THE ENDOVASCULAR TREATMENT OF A PAU. THREE MONTHS POST INDEX, THE PATIENT EXPERIENCED SEVERE CHEST PAINS AND FAINTED. A TYPE IA ENDOLEAK WAS OBSERVED FROM DISEASE PROGRESSION. THE FOLLOWING DAY, A SECONDARY PROCEDURE WAS PERFORMED TO EXTEND THE ENDOGRAFT TO THE LCC. A J-WIRE WAS PLACED FROM THE LEFT GROIN IN PREPARATION WHILE A SECOND SURGEON PERFORMED LCC-LSA BYPASS. AFTER THE BYPASS WAS COMPLETED, AN IVUS WAS TAKEN TO CONFIRM THE AORTIC DIAMETER AT THE LCC. A PIGTAIL CATHETER WAS INTRODUCED FROM THE LEFT RADIAL FOR AN INITIAL RUN WHICH THEN REVEALED A RETROGRADE TYPE A DISSECTION. IT WAS ALSO REPORTED, THE PATIENT SUFFERED AORTIC INSUFFICIENCY AND A PLURAL EFFUSION. THE ENDOVASCULAR TEVAR PROCEDURE WAS CANCELLED AND THE SURGEON PROCEEDED WITH OPEN REPAIR WITH ARCH SEWING ELEPHANT TRUNK TO THE PROXIMAL SEGMENT OF THE EXISTING NAVION GRAFT WAS PERFORMED. THE TYPE IA WAS REPORTED TO BE CAUSED BY DISEASE PROGRESSION. NO CAUSE OF THE DISSECTION WAS REPORTED. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS FINE.
Patient problems: Pain; Pleural Effusion; Syncope/Fainting; Valvular Insufficiency/ Regurgitation; Vascular Dissection
MAUDE report 11869467 ↗
Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page